Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABGFIN study)

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue 2, 2004, Pages 137-143

  Buzzetti, Raffaella ^a   Galgani, A ^a   Petrone, A ^a   Del Buono, M L ^a   Erlich, H A ^b   Bugawan, T L ^b   Lorini, R ^c   Meschi, F ^d   Multari, G ^a   Pozzilli, P ^e   Locatelli, M ^f   Bottazzo, G ^f   Di Mario, U ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c G GASLINI INSTITUTE   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Genetics; Genotype frequency; HLA class II alleles; Incidence; Newborn screening; Prediction; Risk estimation; Sensitivity; Specificity; Type 1 diabetes

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CASE CONTROL STUDY; CLASSIFICATION; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; GENE FREQUENCY; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; IMMUNOLOGICAL PROCEDURES; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; MALE; NEWBORN; POPULATION GENETICS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INCIDENCE; INFANT, NEWBORN; ITALY; MALE; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 11144358602     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.426     Document Type: Article

References (44)

1. Atkinson MA, Mclaren NK. Mechanisms of disease: the pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436.
2. Barnett AH, Eff C, Leslie RDG, et al. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.
3. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992; 35: 1060-1067.
4. Kumar D, Gemayel NS, Deapen D, et al. North-Americans twins with IDDM. Genetic, etiological and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 1993; 42: 1351-1363.
5. Buzzetti R, Nisticò L, Osborn Jf, et al. HLA-DQA1 and DQB1 gene polymorphism in type 1 diabetic patients from central Italy and their use for risk prediction. Diabetes 1993; 42: 1173-1178.
6. Todd JA, Bell JI, McDevitt HO. HLA-DQβ genes contribute to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599-604.
7. Erlich HA, Bugawan TL, Scharf S, et al. HLA - DQβ sequence polymorphism and genetic susceptibility to IDDM. Diabetes 1990; 39: 96-103.
8. Davies JL, Kawaguchi Y, Bennett ST, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-136.
9. Hashimoto L, Habita C, Beressi JP, et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome l1q. Nature 1994; 371: 161-164.
10. Field LL, Tobias R, Magnus T. A locus on chromosome 15q26 (IDDM3) produces susceptibility to IDDM. Nat Genet 1993; 8: 189-194.
11. Owerbach D, Gabbay KH. The HOXD8 locus (2q31) is linked to type 1 diabetes: interaction with chromosomes 6 and 11 disease susceptibility genes. Diabetes 1995; 44: 132-136.
12. Hahl J, Simell T, Ilonen J, et al. Costs of predicting IDDM. Diabetologia 1998; 41: 79-85.
13. Nejentsev S, Sjöroos M, Soukka T, et al. Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 1999; 16: 985-992.
14. Singal DP, Blajchman MA. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 1973; 22: 429-432.
15. Solow H, Hidalgo R, Singal DP. Juvenile-onset diabetes: HLA-A, -B, -C and - DR alloantigens. Diabetes 1979; 28: 1-4.
16. Noble JA, Valdes AM, Cook M, et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-1348.
17. Zamani M, Cassiman JJ. Reevaluation of the importance of polymorphic HLA class II alleles and aminoacids in the susceptibility of individuals of different populations to type 1 diabetes. Am J Hum Genet 1998. 76: 183-194.
18. Nepom G, Erlich HA. MHC class II molecules and autoimmunity. Annu Rev Immunol 1991; 9: 493-525.
19. Erlich HA, Rotter JI, Chang J, et al. HLA class II alleles and susceptibility and resistance to insulin-dependent diabetes mellitus in Mexican-American families. Nat Genet 1993; 3: 358-364.
20. Rønningen KS, Spurkland A, Tait BD, et al. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids and Japanese. HLA 1991, vol. 1. Tsui K, Aizawa M, Sasazuki T (eds). Oxford University Press: Oxford, 1992; 713-722.
21. Thorsby E, Rønningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 371-376.
22. Concannon P, Gogolin-E KJ, Hinds DA, et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998; 19: 292-296.
23. Mein CA, Esposito L, Dunn MG, et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998; 19: 297-300.
24. She JX, Marron MP. Genetic susceptibility factors in type 1 diabetes: linkage disequilibrium and functional analyses. Curr Opin Immunol 1998; 10: 682-689.
25. Cox NJ, Wapelhorst B, Morrison VA, et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 2001; 69: 820-830.
26. Bugawan TL, Erlich HA. Rapid typing of HLA-DQB1 DNA polymorphism using non-radioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991; 33: 163-170.
27. Erlich HA, Bugawan TL, Begovich A, et al. HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur J Immunogenet 1991; 18: 33-55.
28. Rewers M, Bugawan TL, Norris JM, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996; 39: 807-812.
29. Bruno G, Merletti F, Pisu E, et al. Incidence of IDDM during 1984-1986 in population aged <30unsyears. Diabetes Care 1990; 13: 1051-1056.
30. Green A, Gale EAM, Patterson CC. The EURODIAB ACE Study Group. Incidence of childhood-onset insulin-dependent diabetes mellitus: the Eurodiab Ace study. Lancet 1992; 339: 905-909.
31. Sebastiani L, Visalli N, Adorisio E, et al. A 5-year (1989-1993) prospective study of the incidence of IDDM in Rome and the Lazio region in the age-group 0-14. Diabetes Care 1996; 19: 70-73.
32. Karvonen M, Viik-Kajander M, Moltchanova E, et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Care 2000; 23: 1516-1526.
33. Petrone A, Bugawan TL, Mesturino CA, et al. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy. Tissue Antigens 2001; 58: 1-10.
34. Signorelli C. Elementi di Metodologia Epidemiologica. Società Editrice Universo: Rome, Italy, 1992.
35. Patterson CC, Dahlquist G, Soltesz G, et al. Is childhood-onset type 1 diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 2001; 44(Suppl. 3): B9-B16.
36. Petrone A, Battelino T, Krzisnik C, et al. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 2002; 60: 249-258.
37. Hermann R, Mijovic CH, Rayner M, et al. HLA alleles and IDDM in children in Hungary: a comparison with Finland. Hum Immunol 2001; 62: 391-398.
38. Ilonen J, Sjöroos M, Knip M, et al. Estimation of genetic risk for type 1 diabetes. Am J Med Genet 2002; 115: 30-36.
39. Van der Auwera B, Van Waeyenberge C, Schuit F, et al. DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Diabetes 1995; 44: 527-530.
40. Roep BO, Schipper R, Verduyn W, et al. HLA-DRB*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Tissue Antigens 1999; 54: 88-90.
41. Undlien DE, Friede T, Rammensee HG, et al. HLA-encoded genetic predisposition in IDDM. DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143-149.
42. Bennett ST, Wilson AJ, Esposito L, et al., The IMDIAB Group. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. Nat. Genet 1997; 17(3): 350-352.
43. Nisticò L, Buzzetti R, Pritchard LE, et al., Belgian Diabetes Registry. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996; 5(7): 1075-1080.
44. Lampis R, Morelli L, De Virgiliis S, et al. The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens 2000; 56: 515-521.